Beacon Pointe Advisors, LLC

Position in BNTX — BioNTech SE

CIK 1744317 NEWPORT BEACH, CA

Position in BNTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,481,896

-$4,296,268 QoQ

Shares Held

16,673

-72.5% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Beacon Pointe Advisors, LLC holds $39,649,374 across 25 Biotechnology names. BNTX ranks #6 (3.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	19,460	$15,035,574
2	VRTX	Vertex Pharmaceuticals Inc / Ma	17,894	$7,990,386
3	INCY	Incyte Corp	73,301	$6,899,090
4	NUVB	Nuvation Bio Inc.	643,734	$2,761,618
5	SMMT	Summit Therapeutics Inc.	94,394	$1,789,710
6	BNTX	BioNTech SE This page	16,673	$1,481,896
7	HALO	Halozyme Therapeutics, Inc.	10,507	$679,067
8	CRSP	CRISPR Therapeutics AG	12,085	$574,883

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,481,896	16,673	-72.5%	Shares	Sole	2026-05-15
2025-12-31	$5,778,164	60,695	-33.6%	Shares	Sole	2026-02-18
2025-09-30	$9,011,895	91,380	+3.8%	Shares	Sole	2025-11-14
2025-06-30	$9,373,725	88,041	-1.6%	Shares	Sole	2025-08-13
2025-03-31	$8,151,326	89,516	-0.6%	Shares	Sole	2025-05-13
2024-12-31	$10,257,892	90,021	+1.9%	Shares	Sole	2025-02-14
2024-09-30	$10,494,754	88,362	+3.9%	Shares	Sole	2024-11-14
2024-06-30	$6,832,769	85,027	-11.3%	Shares	Sole	2024-08-12
2024-03-31	$8,839,579	95,822	+81.8%	Shares	Sole	2024-05-14
2023-12-31	$5,562,591	52,706	+3259.2%	Shares	Sole	2024-02-08
2022-06-30	$233,937	1,569	+63.6%	Shares	Sole	2022-08-11
2021-09-30	$261,797	959	0.0%	Shares	Sole	2021-11-15
2021-06-30	$214,700	959	—	Shares	Sole	2021-08-17
No filing history on record for this holder in this stock.